AML develops after a lag time of weeks in mice transplanted with bone marrow transduced with MLL1-oncogenes, but we found Triad1-knockdown significantly shortens this latency, suggesting it is a leukemia suppressor (3, 11, 12). The gene discussed is KMT2A; the disease is acute myeloid leukemia.